MedTrace Logo

Internet-Based Education for Prostate Cancer Screening

NCT00623090 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1893

Last updated 2012-12-13

No results posted yet for this study

Summary

Prostate cancer (PCa) is the leading cancer diagnosis among men and the second leading cause of male cancer death. However, screening asymptomatic men remains controversial, as early diagnosis and treatment of PCa has not yet demonstrated reduced disease-related mortality in a randomized trial. The goal of the current study is to develop and assess widely accessible methods to assist men in making informed decisions about PCa screening. We will compare the efficacy of a new web-based, interactive decision support approach to our existing print-based PCa screening decision tool, among a diverse sample of male primary care patients. Abundant evidence documents the expanding role of the Internet in increasing access to and understanding of health information and the need for systematic evaluations of Internet-based interventions. A novel aspect of the proposed trial will be our focus on cognitive biases as a factor that has limited the success of previous information-based interventions. Specifically, we will evaluate: 1) confirmation bias and 2) short-term consequences bias.

Conditions

Interventions

BEHAVIORAL

educational internet site on prostate cancer screening

Healthy men between 45-70 receive the login information to access our educational internet site on prostate cancer screening.

BEHAVIORAL

Educational print booklet

Healthy men between 45-70 receive a copy of our educational print booklet in the mail.

BEHAVIORAL

Usual care

Healthy men aged 45-70 receive no intervention and are followed for one year, along with the men in the two intervention arms.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • National Cancer Institute (NCI)

    collaborator NIH

  • Georgetown University

    lead OTHER

Principal Investigators

  • Kathryn L. Taylor, PhD · Georgetown University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2011-03-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00623090 on ClinicalTrials.gov